Certara Investor Day Presentation Deck

Track record of scientific and regulatory milestones First PBPK workshop to FDA First FDA approval with virtual bioequivalence for complex generic ● ● ● First FDA acceptance of Simcyp simulation in lieu of DDI trial Simcyp used to enable drug to come off FDA clinical safety hold Yesterday Drug-drug interaction model Pediatrics module Animal module Cardiac safety simulator ● ● ● Gene therapy regulatory submission with QSP Today COVID-19 Vaccine Model wins R&D 100 Award Virtual bioequivalence Vaccine simulator Immuno-oncology Immunogenicity ● Secondary pharmacology • Long-acting injectables ● • Gene therapy Neurodegenerative diseases Tomorrow ● 50 CERTARA

View entire presentation